ORIX Corporation filed a Form 6-K with the SEC on November 18, 2026, announcing that two of its subsidiaries, OQCI Fund LP and OFI Fund LP, are expected to qualify as specific subsidiaries of ORIX following the execution of a share transfer agreement and planned capital contributions.
Key Highlights
- Trigger event: On November 18, 2026, ORIX subsidiary OQCI Fund LP, through OQI02 Corporation, executed a share transfer agreement relating to an investment transaction.
- Specific subsidiary status: Capital contributions to OQCI Fund LP and OFI Fund LP are expected to be equivalent to 10% or more of ORIX's common stock, causing both funds to qualify as specific subsidiaries of ORIX.
- Ownership stakes: ORIX holds an indirect equity interest of 60.0% in OQCI Fund LP and a 100.0% equity interest in OFI Fund LP.
- Payment schedule: Payment of capital contributions to both funds is scheduled for early March 2027.
- Financial results (FY25.12): OQCI Fund LP reported net assets of -175 million JPY and total assets of 2 million JPY; OFI Fund LP reported net assets of -105 million JPY and total assets of 1 million JPY.
- Consolidated impact: According to the filing, "the impact of this matter on ORIX's consolidated results for this fiscal year is expected to be immaterial."
ORIX Subsidiary Funds Advance Japan-Focused Investment Platform
According to the Form 6-K filed for the month of November 2026, ORIX Corporation (NYSE:IX) disclosed that OQCI Fund LP, a Cayman Islands exempted limited partnership formed on November 11, 2025, executed a share transfer agreement on November 18, 2026, through its subsidiary OQI02 Corporation. The filing states that as a result of planned capital calls and capital contributions connected to a new investment, OQCI Fund LP is expected to qualify as a specific subsidiary of ORIX. OFI Fund LP, which is an investor in OQCI Fund LP, is also expected to qualify as a specific subsidiary under the same circumstances.
The filing describes OQCI Fund LP as focused on "investments in operating companies in Japan," with its general partner being OQCI GP Ltd., whose directors are listed as Charles Harry Sparrow, Sinead Wagner, and Verity Priest. OFI Fund LP shares the same described business purpose and Cayman Islands domicile, with OFI GP Ltd. serving as its general partner, whose directors are listed as Charles Harry Sparrow and Koichi Nagayama. The filing notes that ORIX receives service fees from OQCI GP Ltd. in connection with its relationship to OQCI Fund LP, and reports no applicable personnel or business relationship with OFI Fund LP.
The filing references a prior announcement dated November 11, 2025, titled "ORIX and QIA Partner to Launch USD 2.5 billion Japan-Targeted Private Equity Platform," in connection with the formation of OQCI Fund LP. The Form 6-K was signed by Masataka Yamada, identified as Member of the Board of Directors, Senior Managing Executive Officer, Chief Financial Officer and Chief Strategy Officer. The filing includes cautionary language noting that forward-looking statements are subject to uncertainties and risks that could cause actual results to differ materially from those described.
What Was Disclosed
ORIX Corporation disclosed via Form 6-K that two subsidiaries, OQCI Fund LP and OFI Fund LP, are expected to become specific subsidiaries of ORIX following a November 18, 2026, share transfer agreement and planned capital contributions, with payment scheduled for early March 2027.



Please wait processing your request...